期刊文献+

冠心病稳定型心绞痛患者降脂治疗临床分析 被引量:2

Clinical analysis of lipid-lowering therapy in patients with stable angina pectoris
原文传递
导出
摘要 目的探讨舒降之对稳定性心绞痛患者血脂的影响。方法选择80例诊断明确的稳定性心绞痛患者,随机分成两组,在常规治疗的基础上治疗组给予辛伐他汀(默沙东制药有限公司生产)20mg,每日晚顿服,4周为1疗程,连续用药3个疗程,观察治疗前后血脂浓度的变化。结果使用辛伐他汀治疗后的患者血清总胆固醇、甘油三脂、低密度脂蛋白显著降低、高密度脂蛋白上升。结论应用辛伐他汀治疗稳定型心绞痛能有效降低血脂水平。 Objective To investigate the stability of simvastatin on blood lipids of patients with angina pectoris.Methods Totally 80 patients with definite diagnosis of unstable angina were randomly divided into two groups,in the conventional therapy group received treatment on the basis of simvastatin(Merck Pharmaceutical Co) 20mg,Daily evening,4 weeks as a course of treatment,continuous administration of three courses,observed changes in blood lipid levels before and after treatment.Results After treatment with simvastatin in patients with serum total cholesterol,triglyceride,low density lipoprotein decreased significantly,increased high-density lipoprotein. Conclusions The treatment of stable angina pectoris with simvastatin can effectively lower blood lipid levels.
作者 侯秀昌
出处 《医药论坛杂志》 2011年第5期118-119,共2页 Journal of Medical Forum
关键词 舒降之 稳定性心绞痛 疗效 Zocor Stable angina Effect
  • 相关文献

参考文献5

二级参考文献35

  • 1陈璐,童荣生.他汀类药物非降脂作用及临床应用展望[J].西部医学,2004,16(4):361-363. 被引量:9
  • 2田静文,方颖,周爱英.急性冠脉综合征初期他汀类药物短期治疗对内皮功能的影响[J].中国药业,2004,13(12):65-67. 被引量:25
  • 3杨大春,朱峻,周兴文,张鑫,陈易华,刘德芳,曾智.冠心病病情和预后评估指标:E-选择素及C-反应蛋白的检测[J].中国临床康复,2005,9(3):52-53. 被引量:6
  • 4王艳霞,张迎春,梁波,张红岩.C反应蛋白对急性冠状动脉综合征转归的预测价值[J].中国心血管杂志,2005,10(4):279-280. 被引量:14
  • 5杜莉.辛伐他汀与利托那韦合用引起横纹肌溶解1例[J].中国医药论坛报,2002,9:12-12.
  • 6张爱玲.阿伐他汀与地尔硫(艹卓)合用导致横纹肌溶解[J].中国医药论坛报,2003,4:10-10.
  • 7Saito M ,Ishimitsu T,Minami J,et al. Relations of Plasma high sensitivity C-reative protein to traditional cardiovascular risk factors. Athemsclerosis,2003,167 ( 1 ) :73-79.
  • 8Albert MA, Danielson E, Rifai N, et al. Effect of sation therapy on C reactive protein levels:the pravastatin inflaznmation/CRP evaluation ( PRINCE ) : arandohazed trial and cohort study. JAMA,2001, 286( 1 ) :64-70.
  • 9Nomenclature and criteria for diagnosis of ischemic heart disease. Report of the joint international socity and federation of cardiology/ world health organization task force on standardization of clinical nomenclature. Circlution, 1979,59 ( 3 ) :607-609.
  • 10Koenig W,Sund M,Frohlieh M et al. C-reaetive Protein,a Sensitive marker of inflammation, Predicts future risk of coronary Heart disease in initially healthy middle-aged men: Results from the MONICA Augsburg Cohort Study, 1984 to 1992 Cireulation, 1999. 99(2) :237-242.

共引文献36

同被引文献10

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部